These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11196625)

  • 1. Cardiovascular biology. Small cells, big issues.
    Brass S
    Nature; 2001 Jan; 409(6817):145, 147. PubMed ID: 11196625
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
    Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
    Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.
    Quinton TM; Kim S; Jin J; Kunapuli SP
    J Thromb Haemost; 2005 May; 3(5):1036-41. PubMed ID: 15869601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid resensitization of purinergic receptor function in human platelets.
    Mundell SJ; Barton JF; Mayo-Martin MB; Hardy AR; Poole AW
    J Thromb Haemost; 2008 Aug; 6(8):1393-404. PubMed ID: 18513210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood flow and thrombogenesis. Correlation of blood platelets, blood coagulation factors and the vascular wall].
    Baumgartner HR
    Internist (Berl); 1984 Feb; 25(2):75-81. PubMed ID: 6323341
    [No Abstract]   [Full Text] [Related]  

  • 7. The platelet ADP receptors.
    Cattaneo M; Gachet C
    Haematologica; 2001 Apr; 86(4):346-8. PubMed ID: 11325637
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors.
    Cristalli G; Podda GM; Costanzi S; Lambertucci C; Lecchi A; Vittori S; Volpini R; Zighetti ML; Cattaneo M
    J Med Chem; 2005 Apr; 48(8):2763-6. PubMed ID: 15828813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
    Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
    Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.
    Becker RC
    J Thromb Thrombolysis; 2000 Aug; 10(1):35-53. PubMed ID: 10947913
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of platelets in blood-surface interactions.
    Salzman EW
    Fed Proc; 1971; 30(5):1503-9. PubMed ID: 4330341
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
    Ferreira IA; Mocking AI; Feijge MA; Gorter G; van Haeften TW; Heemskerk JW; Akkerman JW
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):417-22. PubMed ID: 16339499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate-induced platelet activation and aggregation after administration of a single high dose of clopidogrel.
    Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
    J Thromb Haemost; 2006 Apr; 4(4):912-4. PubMed ID: 16634769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelets, ADP, cAMP, and antiplatelet drugs].
    Gascon G; Trudel J; Rabbat A; Dufault C
    Union Med Can; 1974 Jun; 103(6):1077-82. PubMed ID: 4366039
    [No Abstract]   [Full Text] [Related]  

  • 16. Disorders of platelet function. Abnormalities of the platelet P2 receptors.
    Cattaneo M
    Pathophysiol Haemost Thromb; 2006; 35(1-2):10-4. PubMed ID: 16855340
    [No Abstract]   [Full Text] [Related]  

  • 17. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.
    Hetherington SL; Singh RK; Lodwick D; Thompson JR; Goodall AH; Samani NJ
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):252-7. PubMed ID: 15514209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented.
    Mangin P; Ohlmann P; Eckly A; Cazenave JP; Lanza F; Gachet C
    J Thromb Haemost; 2004 Jun; 2(6):969-77. PubMed ID: 15140133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP and platelets: the end of the beginning.
    Woulfe D; Yang J; Brass L
    J Clin Invest; 2001 Jun; 107(12):1503-5. PubMed ID: 11413156
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of anticoagulants used during blood collection on human platelet function.
    May JA; Heptinstall S
    Methods Mol Biol; 2004; 272():3-11. PubMed ID: 15226530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.